GlassScriptPhysician profile
Matthew D Barr
NPI 1336188127
$5,961.45
in general payments reported to CMS, 2019-2025
26 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,776 · 2022: $596 · 2023: $1,310 · 2024: $974 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,589.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,611.59 | 2021-2025 | Eluvia, General - Atherectomy, Jetstream Sc |
| Medtronic, INC. | $950.21 | 2021-2025 | Abre, Endurant Iis, Concertotm |
| Endologix LLC | $754.80 | 2023-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Bard Peripheral Vascular, INC. | $529.44 | 2021-2023 | Venclose Maven Catheter |
| E.R. Squibb & Sons, L.L.C. | $399.52 | 2021-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $365.10 | 2021-2024 | Xarelto |
| Reflow Medical INC | $183.78 | 2025 | |
| Pfizer INC. | $162.21 | 2021-2024 | |
| Lemaitre Vascular, INC. | $160.91 | 2021-2025 | Hydro Lemaitre Valvulotome, Restoreflow, Syntel Embolectomy Catheter (Spring Tip) |
| Tactile Systems Technology INC | $114.08 | 2021-2025 | Nimbl, Flexitouch Plus |
| Terumo Medical Corporation | $106.99 | 2021-2025 | Azur Cx Detachable, Angio-Seal, Glidesheath Slender |
| Solventum Corporation | $86.92 | 2024-2025 | Promogran Prisma, Prevena, V.A.C. Veraflo |
| Philips North America LLC | $70.22 | 2022-2023 | |
| Alexion Pharmaceuticals, INC. | $68.33 | 2024 | Ultomiris |
| Smith+Nephew, INC. | $49.57 | 2023-2024 | Pico, Renasys Touch |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $49.09 | 2024 | Mynx Control |
| Inari Medical, INC. | $46.55 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $43.44 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Stryker Corporation | $40.76 | 2025 | Artix Mt |
| Penumbra, INC. | $30.59 | 2025 | Indigo System |
| Kerecis Limited | $28.82 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Inspire Medical Systems, INC. | $27.51 | 2025 | Inspire |
| Abbott Laboratories | $24.54 | 2025 | Esprit |
| Abbvie INC. | $22.14 | 2024 | |
| Kci USA, INC. | $19.71 | 2023 | Silvercel, 3m Coban, Kerramax Care |
| Astrazeneca Pharmaceuticals LP | $14.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.